cas 1272668-29-7|| where to buy 1-[4-(3-aminocyclobutyl)piperazin-1-yl]ethan-1-one

Product Name:1-[4-(3-aminocyclobutyl)piperazin-1-yl]ethan-1-one

IUPAC Name:1-[4-(3-aminocyclobutyl)piperazin-1-yl]ethan-1-one

Packing Unit	Available Stock	Price($)
CM440644-250mg	4-5 Weeks	ƿƥŞ
CM440644-500mg	4-5 Weeks	ŵȡŵ
CM440644-1g	5-6 Weeks	ȯǑƿǑ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1272668-29-7 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1272668-29-7; Molecular Formula:C10H19N3O; Melting Point:-; Smiles Code:CC(=O)N1CCN(CC1)C1CC(N)C1; Density:

: Catalog Number:CM440644; Molecular Weight:197.28; Boiling Point:; MDL No:MFCD20703237; Storage:

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.